Remi A. Nout

2009–2025 年に発表

143
論文数
23,618
被引用数
72
h 指数
135
i10 指数

被引用数

Remi A. Nout の年別被引用数1994 年: 被引用 2 件2006 年: 被引用 1 件2010 年: 被引用 6 件2011 年: 被引用 23 件2012 年: 被引用 19 件2013 年: 被引用 21 件2014 年: 被引用 34 件2015 年: 被引用 77 件2016 年: 被引用 132 件2017 年: 被引用 96 件2018 年: 被引用 171 件2019 年: 被引用 687 件2020 年: 被引用 823 件2021 年: 被引用 1,031 件2022 年: 被引用 976 件2023 年: 被引用 856 件2024 年: 被引用 1,392 件2025 年: 被引用 558 件2026 年: 被引用 15 件1995〜2005 年は被引用が無いため表示していません2007〜2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,040 件、この内訳の 15.8%中国: 引用元論文 583 件、この内訳の 8.9%イタリア: 引用元論文 552 件、この内訳の 8.4%オランダ: 引用元論文 444 件、この内訳の 6.7%イギリス: 引用元論文 431 件、この内訳の 6.6%カナダ: 引用元論文 317 件、この内訳の 4.8%フランス: 引用元論文 312 件、この内訳の 4.7%ドイツ: 引用元論文 269 件、この内訳の 4.1%スペイン: 引用元論文 252 件、この内訳の 3.8%日本: 引用元論文 168 件、この内訳の 2.6%オーストリア: 引用元論文 157 件、この内訳の 2.4%デンマーク: 引用元論文 157 件、この内訳の 2.4%
0%15.8%その他 28.8%

分野

  • Medicine83.1%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Physics and Astronomy2.2%
  • Computer Science1.5%
  • Immunology and Microbiology1.4%
  • Engineering0.7%
  • その他1.4%

トピック

  • Endometrial and Cervical Cancer Treatments19.1%
  • Ovarian cancer diagnosis and treatment6.3%
  • Gynecological conditions and treatments3.8%
  • Cervical Cancer and HPV Research3.4%
  • Genetic factors in colorectal cancer3.3%
  • Cancer Immunotherapy and Biomarkers2.7%
  • その他61.4%

共著者

全論文

検索で開く
  1. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2020 被引用: 1,933

  2. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 837

  3. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2023 被引用: 442

  4. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

    著者: , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 858

  5. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Hudej, Taran Paulsen Hellebust, Geetha Menon, Arun S. Oinam, Peter Bownes, Melissa Christiaens, Marisol De Brabandere, Hilde Janssen, B.J. Oosterveld, Kees Koedooder, Anne Beate Langeland Marthinsen, Marit Sundset, Diane Whitney, Martijn Ketelaars, Ludy Lutgens, Brigitte Reinniers, Itxa Mora, E. Villafranca, Gergely Antal, Janaki Hadjiev, François Bachand, Deidre Batchelar, Bradley A. Erickson, Jason Rownd, G. Jacobson, Yusung Kim, Maarit Anttila, Jan-Erik Palmgren, Jusheng An, Marianne S. Assenholt, Susovan Banerjee, Søren M. Bentzen, Thomas Berger, Pittaya Dankulchai, Tamara Diendorfer, Ian Dilworth, Johannes Dimopoulos, E. Dörr, Stefan Ecker, Mario Federico, Elena Fidarova, Israël Fortin, Petra Georg, Joanna Góra, Neamat Hegazy, Noha Jastaniyah, Nina Boje Kibsgaard Jensen, Thomas Liederer, Katarina Majerčáková, Dragan Misimovic, Laura Motisi, Dina Najjari-Jamal, Karen Nkiwane, Anders Schwartz-Vittrup, Monica Serban, Stéphanie Smet, Sofia Spampinato, Petra Trnková, Margit Valgma, Henrike Westerveld, Joyce Siu Yu Wong, Kenji Yoshida - The Lancet Oncology 2021 被引用: 628

  6. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet - Annals of Oncology 2015 被引用: 1,380

  7. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

    著者: , , , , , , , , , , , , , , , , , , - The Journal of Pathology 2019 被引用: 402

  8. Interpretation of somatic POLE mutations in endometrial carcinoma

    著者: , , , , , , , , , , , , - The Journal of Pathology 2019 被引用: 392

  9. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

    著者: , , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2023 被引用: 162

  10. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Digital Health 2022 被引用: 124

  11. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carien L. Creutzberg, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn - Nature Communications 2022 被引用: 144

  12. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    著者: , , , , , , , , , , , , , , , , - The American Journal of Surgical Pathology 2018 被引用: 342

  13. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emma J. Crosbie, Richard J. Edmondson, David N. Church, Alexandra Léary, Linda Mileshkin, Pamela M. Pollock, Helen Mackay - Modern Pathology 2022 被引用: 161

  14. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials

    著者: , , , , , , , , , - European Journal of Cancer 2015 被引用: 430

  15. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2020 被引用: 248

  16. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

    著者: , , , , , , , , , , , , , , - Modern Pathology 2015 被引用: 490

  17. Practical guidance for mismatch repair-deficiency testing in endometrial cancer

    著者: , , , , , , , , , , - Annals of Oncology 2016 被引用: 346

  18. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, LCHW Lutgens, Harry Hollema, E. Pras, An Snyers, Henrike Westerveld, JJ Jobsen, Annerie Slot, JM Mens, TC Stam, Baukelien van Triest, E. van der Steen-Banasik, K. Winter, MA Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Alessandro Colombo, Silvestro Carinelli, Annamaria Ferrero, Grazia Artioli, Catherine Davidson, C. Meg McLachlin, Prafull Ghatage, PVC Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, D Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2019 被引用: 456

  19. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, Roy F.P.M. Kruitwagen, Harry Hollema, E. Pras, An Snyers, Lukas L Stalpers, Jan J. Jobsen, Annerie Slot, Jan-Willem M. Mens, Tanja C. Stam, Baukelien van Triest, Elzbieta M. Van der Steen - Banasik, Karin A.J. De Winter, Michael Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Sergio Gribaudo, Andrea Alberto Lissoni, Annamaria Ferrero, Grazia Artioli, Cathy N. Davidson, C. Meg McLachlin, Prafull Ghatage, Paula V.C. Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, Dominique Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2018 被引用: 623

  20. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cancer 2021 被引用: 156

  21. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

    著者: , , , , , , , , , , - International Journal of Gynecological Cancer 2015 被引用: 757

  22. Incorporation of molecular characteristics into endometrial cancer management

    著者: , , , - Histopathology 2019 被引用: 299

  23. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E.M. van de Steen-Banasik, Marika C. Stenfert Kroese, L.A.M. Pop, Lon Uitterhoeve, A. Snijders-Keilholz, Bart N.F.M. van Bunningen, J. Biesta, F.M. Gescher, J. Pomp, Otto W.M. Meijer, Jan Tabak, Annerie Slot, Ì.M. Jürgenliemk-Schulz, Elzbieta M. van der Steen‐Banasik, Jan Willem Mens, Remi A. Nout, Vincent T.H.B.M. Smit, J.W.H. Leer, Paul R. Timmer, Baukelien van Triest, Betty Pras, Ruud Wiggenraad, F. Gescher, V. Coen - Journal of Clinical Oncology 2023 被引用: 98

  24. Prediction of recurrence risk in endometrial cancer with multimodal deep learning

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2024 被引用: 88